---
title: "CIK cell therapies in infectious disease: evidence and translational perspectives"
id: "pubmed-43024081"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43024081"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43024081/"
doi: "10.1007/s00281-026-01092-x"
published_at: "2026-11-13T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# CIK cell therapies in infectious disease: evidence and translational perspectives
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43024081
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43024081/)
- **DOI:** [10.1007/s00281-026-01092-x](https://doi.org/10.1007%2Fs00281-026-01092-x)
- **Published At:** 2026-11-13T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The global burden of infectious diseases and antimicrobial resistance motivates alternative therapeutic strategies beyond standard antimicrobials. - The review centers on clinically licensed **cytokine-induced killer (CIK) cells**, originally used in oncology, and examines their potential application against pathogens. - Investigators reported in vitro data showing CIK cells reduced Plasmodium-infected erythrocytes; the source did not report clinical trial outcomes or dosing details for infectious indications. - The authors compared CIK cells to other effector populations—**CTLs**, **γδT cells**, and **NK cells**—noting differences in biology, recognition mechanisms, and cytotoxic functions. - The review details CIK cell phenotypes, activation strategies, and effector functions based on existing oncology and limited infection-specific studies. - Data indicated preliminary antiviral and antimicrobial activity in select settings, but broader antimicrobial applicability, comparative efficacy, target specificity, safety, and clinical benefit remain unresolved. - The authors emphasized the need for further targeted preclinical and clinical evaluation; specifics on trial design, endpoints, or regulatory milestones were not provided in the abstract. - Conflict-of-interest: authors declared no competing interests. - The review aggregates mechanistic and experimental evidence but explicitly states that many translational questions require additional study before clinical adoption.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43024081/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43024081%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43024081/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43024081/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43024081/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43024081/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43024081/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43024081%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43024081%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43024081/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43024081/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43024081/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43024081/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43024081/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43024081/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43024081/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43024081/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43024081/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43024081/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43024081/#mesh-terms) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Review Semin Immunopathol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Semin+Immunopathol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Semin+Immunopathol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) . 2026 Nov 13;48(1):24. doi: 10.1007/s00281-026-01092-x. # Cell-based immunotherapies for infectious diseases: current evidence and translational perspectives on cytokine induced killer (CIK) cells [Rohulla Vaseq](https://pubmed.ncbi.nlm.nih.gov/?term=Vaseq+R&cauthor_id=43024081)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-1 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany."), [Nahid Mahleqa](https://pubmed.ncbi.nlm.nih.gov/?term=Mahleqa+N&cauthor_id=43024081)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-1 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany."), [Arefa Mohammadi](https://pubmed.ncbi.nlm.nih.gov/?term=Mohammadi+A&cauthor_id=43024081)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-2 "Public Health Faculty, Kabul University of Medical Sciences, Kabul, Afghanistan."), [Marc P Hübner](https://pubmed.ncbi.nlm.nih.gov/?term=H%C3%BCbner+MP&cauthor_id=43024081)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-3 "Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, University Hospital Bonn, 53127, Bonn, Germany.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-4 "German Center for Infection Research \(DZIF\), partner site Bonn-Cologne, Bonn, Germany."), [Hans Weiher](https://pubmed.ncbi.nlm.nih.gov/?term=Weiher+H&cauthor_id=43024081)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-5 "Department of Applied Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany."), [Ingo G H Schmidt-Wolf](https://pubmed.ncbi.nlm.nih.gov/?term=Schmidt-Wolf+IGH&cauthor_id=43024081)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#full-view-affiliation-6 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. Ingo.Schmidt-Wolf@ukbonn.de.") Affiliations Expand ### Affiliations * 1 Department of Integrated Oncology, Center for Integrated Oncology (CIO), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. * 2 Public Health Faculty, Kabul University of Medical Sciences, Kabul, Afghanistan. * 3 Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. * 4 German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany. * 5 Department of Applied Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany. * 6 Department of Integrated Oncology, Center for Integrated Oncology (CIO), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. Ingo.Schmidt-Wolf@ukbonn.de. * PMID: **43024081** * DOI: [ 10.1007/s00281-026-01092-x ](https://doi.org/10.1007/s00281-026-01092-x) Item in Clipboard Review # Cell-based immunotherapies for infectious diseases: current evidence and translational perspectives on cytokine induced killer (CIK) cells Rohulla Vaseq et al. Semin Immunopathol. 2026. Show details Display options Display options Format Abstract PubMed PMID Semin Immunopathol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Semin+Immunopathol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Semin+Immunopathol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) . 2026 Nov 13;48(1):24. doi: 10.1007/s00281-026-01092-x. ### Authors [Rohulla Vaseq](https://pubmed.ncbi.nlm.nih.gov/?term=Vaseq+R&cauthor_id=43024081)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-1 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany."), [Nahid Mahleqa](https://pubmed.ncbi.nlm.nih.gov/?term=Mahleqa+N&cauthor_id=43024081)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-1 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany."), [Arefa Mohammadi](https://pubmed.ncbi.nlm.nih.gov/?term=Mohammadi+A&cauthor_id=43024081)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-2 "Public Health Faculty, Kabul University of Medical Sciences, Kabul, Afghanistan."), [Marc P Hübner](https://pubmed.ncbi.nlm.nih.gov/?term=H%C3%BCbner+MP&cauthor_id=43024081)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-3 "Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, University Hospital Bonn, 53127, Bonn, Germany.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-4 "German Center for Infection Research \(DZIF\), partner site Bonn-Cologne, Bonn, Germany."), [Hans Weiher](https://pubmed.ncbi.nlm.nih.gov/?term=Weiher+H&cauthor_id=43024081)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-5 "Department of Applied Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany."), [Ingo G H Schmidt-Wolf](https://pubmed.ncbi.nlm.nih.gov/?term=Schmidt-Wolf+IGH&cauthor_id=43024081)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43024081/#short-view-affiliation-6 "Department of Integrated Oncology, Center for Integrated Oncology \(CIO\), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. Ingo.Schmidt-Wolf@ukbonn.de.") ### Affiliations * 1 Department of Integrated Oncology, Center for Integrated Oncology (CIO), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. * 2 Public Health Faculty, Kabul University of Medical Sciences, Kabul, Afghanistan. * 3 Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. * 4 German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany. * 5 Department of Applied Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany. * 6 Department of Integrated Oncology, Center for Integrated Oncology (CIO), University of Bonn, University Hospital Bonn, 53127, Bonn, Germany. Ingo.Schmidt-Wolf@ukbonn.de. * PMID: **43024081** * DOI: [ 10.1007/s00281-026-01092-x ](https://doi.org/10.1007/s00281-026-01092-x) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract The persistent global burden of infectious diseases, compounded by environmental challenges, emerging pathogens, and antimicrobial resistance, underscores the urgent need for novel therapeutic strategies beyond conventional antimicrobial agents. Cell based immunotherapies, which harness the body's immune system to combat pathogens, have gained increasing attention for their potential to provide targeted, durable, and adaptive responses. Recently, we demonstrated that clinically licensed cytokine-induced killer (CIK) cells, used in cancer treatment, significantly reduced Plasmodium-infected erythrocytes in vitro. This review focuses on the emerging role of CIK cells in infectious disease therapy, positioning them alongside other prominent immune effector cells such as CTLs, γδT cells, and NK cells. We explore the biology, recognition mechanisms, their potential feature, and cytotoxic functions of these cell populations, distinguishing direct findings in infection-specific CIK studies from mechanisms characterized in oncology or other cytotoxic lymphocytes. While CTLs, γδT cells, and NK cells have been extensively studied for their roles in early and adaptive immune responses, CIK cells traditionally investigated in oncology, are now being recognized for their potential in antiviral and antimicrobial immunity. Alongside with CTLs, γδT cells, and NK cells, we detail CIK cell phenotypes, activation strategies, effector functions, and the limited but growing body of evidence supporting their application in some viral infections. The available findings support further investigation of CIK cells as a candidate approach in selected infectious settings, while their broader antimicrobial applicability, comparative efficacy, target specificity, safety, and clinical benefit require further evaluation in these settings. **Keywords:** CIK cells; CTLs; Cell therapy; Immunotherapy; Infection; NK cells; Pathogen; γδT cells. © 2026. The Author(s). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Ethical approval: NA. Competing interests: The authors declare no competing interests. ## References 1. 1. Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL et al (2022) Infectious disease in an era of global change. Nat Rev Microbiol 20(4):193–205 - [DOI](https://doi.org/10.1038/s41579-021-00639-z) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/34646006/) 2. 1. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629–655 - [DOI](https://doi.org/10.1016/s0140-6736\(21\)02724-0) 3. 1. Walsh TR, Gales AC, Laxminarayan R, Dodd PC (2023) Antimicrobial Resistance: Addressing a Global Threat to Humanity. PLoS Med 20(7):e1004264 - [PubMed](https://pubmed.ncbi.nlm.nih.gov/37399216/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/10317217/) - [DOI](https://doi.org/10.1371/journal.pmed.1004264) 4. 1. Tong MX, Hansen A, Hanson-Easey S, Cameron S, Xiang J, Liu Q et al (2015) Infectious diseases, urbanization and climate change: Challenges in future China [Internet]. International Journal of Environmental Research and Public Health, vol 12. Multidisciplinary Digital Publishing Institute, pp 11025–11036 5. 1. Balanescu AR, Citera G, Pascual-Ramos V, Bhatt DL, Connell CA, Gold D et al (2022) Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial. Ann Rheum Dis 81(11):1491 - [PubMed](https://pubmed.ncbi.nlm.nih.gov/35922124/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/9606533/) - [DOI](https://doi.org/10.1136/ard-2022-222405) Show all 298 references ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Cell- and Tissue-Based Therapy* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell-+and+Tissue-Based+Therapy%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell-+and+Tissue-Based+Therapy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Communicable Diseases* / etiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Communicable+Diseases%2Fetiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Communicable+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Communicable Diseases* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Communicable+Diseases%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Communicable+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Communicable Diseases* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Communicable+Diseases%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Communicable+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Communicable Diseases* / therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Communicable+Diseases%2Ftherapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Communicable+Diseases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Cytokine-Induced Killer Cells* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cytokine-Induced+Killer+Cells%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cytokine-Induced+Killer+Cells) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43024081/) * Cytokine-Induced Killer Cells* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cytokine-Induced+Killer+Cells%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cytokine-Induced+Killer+Cells) *
## Related Clinical Research

- [Herpesvirus–autoantigen antibody networks linked to chronic disease in large biobank profiling](https://medichelpline.com/clinical-feed/nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen.md)
- [Nuclear-transport–targeting peptides (SN50 family) as broad anti-inflammatory agents](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-targeting-the-nuclear-gateway-a-new-class-of-cell-penetrating-peptides-for.md)
- [Lipid droplets regulate macrophage resolution and phagocytic capacity](https://medichelpline.com/clinical-feed/frontiers-in-immunology-4-lipid-droplets-as-the-metabolic-switch-of-macrophage-resolution.md)
- [Protocol For The Feasibility Study Of INSPIRE: Informal Caregivers Of Frail RA Patients](https://medichelpline.com/clinical-feed/clinicaltrials-nct07442773.md) (DOI: NCT07442773)
- [Tissue-resident immune cells and genetic risk in autoimmune and lung diseases](https://medichelpline.com/clinical-feed/nature-immunology-1-tissue-resident-immune-cells-drive-genetic-risk-in-autoimmune-and-lung-diseases.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.